Endometrial cancer
Cancer
Ipsen Initiates An Advanced Endometrial Cancer Program With BN83495, Its First-in-Class Steroid Sulfatase Inhibitor First Patient Dosed In Phase II...trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer. BN83495 is currently being studied in several clinical studies in patients with... In this article: Endometrial cancer, Steroid, Cancer, Hormone, Dehydroepiandrosterone, Surgery, Breast cancer, Androstenediol, and American Cancer Society |
-
Reuters | 5 days ago
UPDATE 1-Aeterna shares up on cancer trial data
...said its uterus cancer treatment met its primary goal in a mid-stage trial. The Quebec City-based company said its compound to treat endometrial cancer, which affects the lining of the uterus, exceeded its goal of a positive response in...
In this article: Cancer, Aeterna Zentaris, Quebec City, and Europe
-
PR Newswire: Health / Biotech | 5 days ago
AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer
AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer Primary efficacy endpoint has been met for patients with advanced-stage or recurrent...
In this article: Cancer, LHRH, Ovarian cancer, Peptide, Doxorubicin, Europe, Safe harbor, and University of Gottingen
-
TIME | November 18, 2009
Can We Talk...About My Breasts
...Laboratories from pregnant mare's urine, was the nation's leading menopausal drug. But in the 1970's, doctors learned that Premarin caused endometrial cancer. Predictably, sales of Premarin plummeted, as woman appropriately stayed away.
In this article: Breast cancer, Cancer, Biopsy, Premarin, Progestin, Hormone, Mastectomy, and Estrogen
-
Centre Daily Times | November 17, 2009
Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor XL147 (SAR245408) in Combination with Paclitaxel and Carboplatin at the AACR-NCI-EORTC Conference
...will be dose-escalated up to 175 mg/m2 and AUC 6, respectively, with expansion at the maximum tolerated dose (MTD) in patients with endometrial and ovarian cancer. In Part B, paclitaxel and carboplatin will be dose-escalated up to...
In this article: Carboplatin, Paclitaxel, Cancer, Platinum, Daiichi-Sankyo, Thrombocytopenia, Amplification, Biopsy, Anorexia, and Adenocarcinoma
-
Obesity causes 100,000 U.S. cancer cases, group says
...number will likely rise as Americans get fatter, researchers said on Thursday. Having too much body fat causes nearly half the cases of endometrial cancer -- a type of cancer of the uterus -- and a third of esophageal cancer cases, the...
In this article: Cancer, Obesity, United States, American Cancer Society, American Institute for Cancer Research, and Esophageal cancer
-
MedicineNet | November 05, 2009
Obesity Linked to Many Cancer Cases in U.S.
...was tied to several cancers. Those included cancer of the esophagus, pancreas, and kidneys. It also included colorectal cancer and endometrial cancer (a form of uterine cancer). Researchers also said it was "probable" that excess abdominal...
In this article: Cancer, Obesity, Breast cancer, U.S., American Institute for Cancer Research, and Sugar
-
USATODAY.com | November 05, 2009
Obesity linked to specific cancers
In this article: Cancer, Obesity, Insulin, Breast cancer, Estrogen, Insulin resistance, American Institute for Cancer Research, Multiple myeloma, and Hormone
-
Coffee may lower endometrial cancer risk
By Joene Hendry NEW YORK (Reuters Health) - Women dread a diagnosis of endometrial cancer, but those who drink at least two cups of caffeinated coffee a day may have a lower risk for this cancer of cells lining the uterus. Coffee...
In this article: Cancer, Caffeine, Estrogen, Reuters Health, Stockholm, Sweden, and NEW YORK
Trends
Loading...
More on Endometrial cancer
Description from Wikipedia:
Endometrial cancer refers to several types of malignancy which arise from the endometrium, or lining of the uterus. Endometrial cancers are the most common gynecologic cancers in the United States, with over 35,000 women diagnosed each year in the U.S. The most common subtype, endometrioid adenocarcinoma, typically occurs within a few decades of menopause, is associated with excessive estrogen exposure, often develops in the setting of endometrial hyperplasia, and presents most often with vaginal bleeding. Endometrial carcinoma is the third most common cause of gynecologic cancer death (behind ovarian and cervical cancer). A total abdominal hysterectomy (surgical removal of the uterus) with bilateral salpingo-oophorectomy is the most common therapeutic approach.
Endometrial cancer may sometimes be referred to as uterine cancer. However, different cancers may develop not only from the endometrium itself but also from other tissues of the uterus, including cervical cancer, sarcoma of the myometrium, and trophoblastic disease.
Explore everything named Endometrial cancer...
